<DOC>
	<DOCNO>NCT01594996</DOCNO>
	<brief_summary>The purpose retrospective observational study evaluate characteristic patient receive Seroquel XR treatment Major Depressive Disorder . The study also investigate medication use patient difference drug utilisation include country . The study observe patient initiate Seroquel XR 9 month period correspond 3 12 month follow launch product country MDD indication . A drug utilisation questionnaire use collect study data patient ' medical record .</brief_summary>
	<brief_title>European Drug Utilization Study</brief_title>
	<detailed_description>A Multinational , Multicenter , Retrospective , Observational Drug Utilisation Study Seroquel Extended Release ( XR ) Prescribed Psychiatrists Treatment Major Depressive Disorder ( MDD ) Selected Countries European Union ( EU )</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision inform consent initiation collection questionnaire data . Documented clinical diagnosis Major Depressive Disorder , Single Episode , Recurrent . Initiation Seroquel XR treatment MDD period define inception cohort , i.e . 3 month launch index date ( 12 month launch ) . If participate clinical trial time 3 month launch index date , patient take part study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Seroquel XR</keyword>
	<keyword>Quetiapine XR</keyword>
	<keyword>Drug utilization</keyword>
	<keyword>Major depressive disorder ( MDD )</keyword>
</DOC>